Circumdatin D Exerts Neuroprotective Effects by Attenuating LPS-Induced Pro-Inflammatory Responses and Downregulating Acetylcholinesterase Activity In Vitro and In Vivo-Reference-Cited by-同舟云学术

Circumdatin D Exerts Neuroprotective Effects by Attenuating LPS-Induced Pro-Inflammatory Responses and Downregulating Acetylcholinesterase Activity In Vitro and In Vivo

Published:2020-05-25 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Zhang Chanjuan,Hu Likun,Liu Dong,Huang Jian,Lin Wenhan

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference54 articles.

1. Metformin attenuates Aβ pathology mediated through levamisole sensitive nicotinic acetylcholine receptors in a C. elegans model of Alzheimer's disease;Ahmad;Mol. Neurobiol.,2017

2. A review on cholinesterase inhibitors for Alzheimer's disease;Anand;Arch. Pharm. Res.,2013

3. The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer disease;Beach;J. Neuropathol. Exp. Neurol.,2000

4. Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care;Behrens;Int. Psychogeriatr.,2018

5. Cholecystokinin antagonists. synthesis of asperlicin analogs with improved potency and water solubility;Bock;J. Med. Chem.,1986

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Possible Prophylactic Effects of Sulforaphane on LPS-Induced Recognition Memory Impairment Mediated by Regulating Oxidative Stress and Neuroinflammatory Proteins in the Prefrontal Cortex Region of the Brain;Biomedicines;2024-05-16

2. Metabolic engineering of fungal secondary metabolism in plants for stress tolerance;Fungal Secondary Metabolites;2024

3. Pyrrolobenzodiazepines: natural sources, therapeutic uses, and future in neurological treatments;Medicinal Chemistry Research;2023-12-18

4. Inflammatory signaling pathways in the treatment of Alzheimer's disease with inhibitors, natural products and metabolites (Review);International Journal of Molecular Medicine;2023-10-04

5. The Rare Marine Bioactive Compounds in Neurological Disorders and Diseases: Is the Blood-Brain Barrier an Obstacle or a Target?;Marine Drugs;2023-07-18